Determination of Non-HDL cholesterol in diabetic and hypertensive patients

American Journal of Therapeutics

Volumn 17, Issue 3, 2010, Pages 337-340

  Contreras, Freddy ^a   Lares, Mary ^b   Castro, Jorge ^b   Velasco, Manuel ^a   Rojas, Joselyn ^c   Guerra, Xavier ^c   Chacín, Maricarmen ^c   Dowling, Victoria ^c   Bermúdez, Valmore ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Dr Carlos Arvelo Hospital   (Venezuela)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Atherosclerosis; LDL; Non HDL cholesterol

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 77952501915     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181c1233c     Document Type: Article

References (10)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
2. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult Treatment Panel II). Circulation. 1994;89:1329-1445.
3. Frost PH, Havel RJ. Rationale for use of non-high density lipoprotein cholesterol rather than low-density lipopro-tein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol. 1998;81:26B-31B.
4. Krauss RM. Atherogenicity of triglyceride-rich lipopro-teins. Am J Cardiol. 1998;81:13B-17B.
5. Cui Y, Blumenthal S, Flaws JA, et al. Non-high density cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413-1419.
6. Rywik S, Manolio T, Pajak A, et al. Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United Status Collaborative Study on Cardiovascular Epidemiology). Am J Cardiol. 1999;84:540-548.
7. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-1907.
8. Friedewald WT, Levi RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
9. Menotti A, Spagnolo A, Scanga M, et al. Multivariate prediction of coronary death in a 10 year follow-up of Italian occupational male cohort. Acta Cardiol. 1992;47:311-320.
10. Castro J, Lares M, Obregon O. El colesterol no HDL como marcador del riesgo cardiovascular. Salus Militiae. 2004:29:3-6.